Skip to main content
Premium Trial:

Request an Annual Quote

Where They Hail From

New Zealand is turning to genomics to figure out where its new coronavirus outbreak came from, the Newsroom reports.

New Zealand appeared to largely have its COVID-19 outbreak under control, as it logged 102 days without a locally transmitted case, as BBC News reports. However, four family members were discovered earlier this week to have COVID-19 and an additional 14 new cases — 13 of whom have ties to the affected family and one person arrived from abroad — have been reported, it adds. It notes Auckland has been placed into a three-day lockdown and the affected individuals quarantined.

According to the Newsroom, New Zealand is turning to genome sequencing in combination with contact tracing to try to tease out the origins of the four initial new cases. They plan to compare the sequences of those new cases to the viral sequences from individuals in isolation and quarantine facilities as well as to global viral strains.

"That will help us track where this virus may have arisen from and then gotten out into the community," Director-General of Health Ashley Bloomfield says, according to the Newsroom.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.